Yazdan Mirzanejad

1.4k total citations
22 papers, 753 citations indexed

About

Yazdan Mirzanejad is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yazdan Mirzanejad has authored 22 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Infectious Diseases and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yazdan Mirzanejad's work include Sepsis Diagnosis and Treatment (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Yazdan Mirzanejad is often cited by papers focused on Sepsis Diagnosis and Treatment (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Yazdan Mirzanejad collaborates with scholars based in Canada, United States and Italy. Yazdan Mirzanejad's co-authors include Anand Kumar, Peter Dodek, Aseem Kumar, Dennis G. Maki, Joseph E. Parrillo, Yaseen M. Arabi, Steve Doucette, Daniel Feinstein, Peter Ellis and Denny Laporta and has published in prestigious journals such as CHEST Journal, Critical Care Medicine and Emerging infectious diseases.

In The Last Decade

Yazdan Mirzanejad

21 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yazdan Mirzanejad Canada 13 356 183 174 143 126 22 753
Shravan Kethireddy United States 12 423 1.2× 260 1.4× 125 0.7× 146 1.0× 64 0.5× 23 714
Bruno Viaggi Italy 17 249 0.7× 113 0.6× 209 1.2× 76 0.5× 121 1.0× 47 665
Jeannie D. Chan United States 20 267 0.8× 303 1.7× 140 0.8× 153 1.1× 149 1.2× 53 1.1k
Sumathi Nambiar United States 17 241 0.7× 188 1.0× 241 1.4× 75 0.5× 98 0.8× 37 911
Aurora Pop‐Vicas United States 16 478 1.3× 257 1.4× 83 0.5× 135 0.9× 114 0.9× 42 982
Cristina Vazquez Guillamet United States 19 515 1.4× 199 1.1× 158 0.9× 256 1.8× 192 1.5× 40 1.2k
Joël Cousson France 14 430 1.2× 133 0.7× 139 0.8× 226 1.6× 59 0.5× 22 710
Emilio Maseda Spain 17 398 1.1× 262 1.4× 137 0.8× 453 3.2× 75 0.6× 83 1.1k
Lala M. Dunbar United States 16 465 1.3× 396 2.2× 258 1.5× 104 0.7× 254 2.0× 22 1.1k
Stéphane Paulus United Kingdom 16 338 0.9× 89 0.5× 138 0.8× 60 0.4× 99 0.8× 41 665

Countries citing papers authored by Yazdan Mirzanejad

Since Specialization
Citations

This map shows the geographic impact of Yazdan Mirzanejad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yazdan Mirzanejad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yazdan Mirzanejad more than expected).

Fields of papers citing papers by Yazdan Mirzanejad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yazdan Mirzanejad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yazdan Mirzanejad. The network helps show where Yazdan Mirzanejad may publish in the future.

Co-authorship network of co-authors of Yazdan Mirzanejad

This figure shows the co-authorship network connecting the top 25 collaborators of Yazdan Mirzanejad. A scholar is included among the top collaborators of Yazdan Mirzanejad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yazdan Mirzanejad. Yazdan Mirzanejad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walkty, Andrew, Heather J. Adam, Melanie Baxter, et al.. (2025). Distribution and antimicrobial susceptibility profile of pathogens recovered from the bloodstream of Canadian patients: results from the CANWARD study (2007–23). Journal of Antimicrobial Chemotherapy. 80(Supplement_2). ii72–ii82. 1 indexed citations
2.
Zhanel, George G., Melanie Baxter, Yazdan Mirzanejad, et al.. (2024). Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022–2024: results from the CLEAR registry. Expert Review of Anti-infective Therapy. 22(12). 1221–1228. 1 indexed citations
3.
Zhanel, George G., Melanie Baxter, Yazdan Mirzanejad, et al.. (2023). Real-life experience with IV fosfomycin in Canada: Results from the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registry. Journal of Global Antimicrobial Resistance. 33. 171–176. 12 indexed citations
4.
Chapman, Michael, et al.. (2022). Successful treatment of suspected early form of chronic Chagas cardiomyopathy: a case report. European Heart Journal - Case Reports. 6(10). ytac403–ytac403. 1 indexed citations
5.
Mirzanejad, Yazdan, et al.. (2021). Laboratory Exposures from an Unsuspected Case of Human Infection with Brucella canis. Emerging infectious diseases. 27(9). 2489–2491. 6 indexed citations
6.
Chorlton, Samuel D., John R. Tyson, Ghada N. Al‐Rawahi, et al.. (2021). COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report. International Journal of Infectious Diseases. 114. 178–182. 39 indexed citations
7.
Speiser, Jaime L., Constantine Karvellas, Wendy Sligl, et al.. (2018). Predicting in-hospital mortality in pneumonia-associated septic shock patients using a classification and regression tree: a nested cohort study. Journal of Intensive Care. 6(1). 66–66. 12 indexed citations
8.
Mohammadi, Ghazaleh, Leila Dargahi, Yazdan Mirzanejad, et al.. (2018). Probiotic mixture of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 attenuates hippocampal apoptosis induced by lipopolysaccharide in rats. International Microbiology. 22(3). 317–323. 37 indexed citations
9.
Boggild, Andrea K., J Geduld, Michael Libman, et al.. (2018). Spectrum of illness in migrants to Canada: sentinel surveillance through CanTravNet. Journal of Travel Medicine. 26(2). 12 indexed citations
10.
Chapman, Michael, et al.. (2017). Experience with High Dose Once-daily Vancomycin for Patients with Skin and Soft-tissue infections in an Ambulatory Setting. Open Forum Infectious Diseases. 4(suppl_1). S338–S338. 2 indexed citations
11.
Boggild, Andrea K., J Geduld, Michael Libman, et al.. (2017). Surveillance report of Zika virus among Canadian travellers returning from the Americas. Canadian Medical Association Journal. 189(9). E334–E340. 23 indexed citations
12.
Kethireddy, Shravan, Beliz Bilgili, H. Lester Kirchner, et al.. (2017). Culture-Negative Septic Shock Compared With Culture-Positive Septic Shock: A Retrospective Cohort Study. Critical Care Medicine. 46(4). 506–512. 47 indexed citations
13.
Karvellas, Constantine, Juan G. Abraldeṣ, Sergio Zepeda-Gómez, et al.. (2016). The impact of delayed biliary decompression and anti‐microbial therapy in 260 patients with cholangitis‐associated septic shock. Alimentary Pharmacology & Therapeutics. 44(7). 755–766. 50 indexed citations
14.
Zuberi, Daniyal, et al.. (2015). Mobilising for safer care: addressing structural barriers to reducing healthcare-associated infections in Vancouver, Canada. Health Sociology Review. 24(2). 137–151. 2 indexed citations
15.
Afra, Kevin, et al.. (2014). 750Effectiveness, Safety, and Impact on Healthcare Decongestion by a Busy Canadian Infusion Centre for Outpatient Parenteral Antimicrobial Therapy. Open Forum Infectious Diseases. 1(suppl_1). S212–S212. 1 indexed citations
16.
Kethireddy, Shravan, R. Bruce Light, Yazdan Mirzanejad, et al.. (2013). Mycobacterium tuberculosis Septic Shock. CHEST Journal. 144(2). 474–482. 50 indexed citations
17.
Zelenitsky, Sheryl, Ethan Rubinstein, Robert E. Ariano, et al.. (2013). Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock. International Journal of Antimicrobial Agents. 41(3). 255–260. 90 indexed citations
18.
Kumar, Anand, Ryan Zarychanski, Bruce Light, et al.. (2010). Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*. Critical Care Medicine. 38(9). 1773–1785. 302 indexed citations
19.
20.
Mirzanejad, Yazdan, et al.. (1996). Colletotrichum sp.: Plant or human pathogen?. 15(3-4). 26–27. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shravan Kethireddy Breakdown of academic impact, for papers by Bruno Viaggi Breakdown of academic impact, for papers by Jeannie D. Chan Breakdown of academic impact, for papers by Sumathi Nambiar Breakdown of academic impact, for papers by Aurora Pop‐Vicas Breakdown of academic impact, for papers by Cristina Vazquez Guillamet Breakdown of academic impact, for papers by Joël Cousson Breakdown of academic impact, for papers by Emilio Maseda Breakdown of academic impact, for papers by Lala M. Dunbar Breakdown of academic impact, for papers by Stéphane Paulus
Rankless by CCL
2026